Epidemiology and Pathophysiology of Multiple Sclerosis : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …

Metabolic syndrome, which includes diabetes and obesity, is one of the most widespread
medical conditions. It induces systemic inflammation, causing far reaching effects on the …

Comorbidities in patients with multiple sclerosis (MS) has become an area of increasing
interest in the recent years. A comorbidity is defined as any additional disease that coexists …

The Canadian Multiple Sclerosis Working Group has updated its treatment optimization
recommendations (TORs) on the optimal use of disease-modifying therapies for patients …

Multiple sclerosis (MS) is a chronic progressive disabling disease of the central nervous
system (CNS) characterized by demyelination and neuronal injury. Dyslipidemia is observed …

Relapses and progression contribute to multiple sclerosis (MS) disease course, but neither
the relationship between them nor the spectrum of clinical heterogeneity has been fully …

Objective: To evaluate the association between comorbidity and relapse rate in individuals
with multiple sclerosis (MS). Methods: We recruited individuals with prevalent relapsing …

Background Cardiovascular diseases (CVD s) are more frequent in multiple sclerosis (MS)
patients when compared to controls. In particular, CVD s are linked with higher accumulation …

Introduction: The interactions between Diabetes Mellitus type II (DMII) and Multiple Sclerosis
(MS) lead to higher levels of fatigue, higher risk of physical disability, faster cognitive …

The deep and periventricular white matter is preferentially affected in several neurological
disorders, including cerebral small vessel disease (SVD) and multiple sclerosis (MS) …